BioCentury
ARTICLE | Financial News

TapImmune shares climb on $70M offering

June 8, 2018 7:14 PM UTC

TapImmune (NASDAQ:TPIV) jumped $3.05 (51%) to $9 Friday after it priced a $70 million private placement led by new investor New Enterprise Associates. The company is selling 17.5 million shares at $4. New investors Aisling Capital and Perceptive Advisors also participated as did other undisclosed new and existing investors.

The price is a 33% discount to TapImmune's Thursday close of $5.95. Investors will also receive five-year warrants to purchase 13.1 million shares at $5...